SHINPOONG PHARMACEUTICAL CO.,LTD Logo

SHINPOONG PHARMACEUTICAL CO.,LTD

Develops and manufactures pharmaceuticals, APIs, and medical devices for global markets.

019170 | KO

Overview

Corporate Details

ISIN(s):
KR7019170000
LEI:
Country:
South Korea
Address:
경기도 안산시 단원구 원시로 7, 안산시

Description

SHINPOONG PHARMACEUTICAL CO.,LTD. is a research and development-oriented pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's portfolio includes finished products such as cephalosporin and penicillin antibiotics, antivirals, anticancer drugs, and painkillers. It also develops and supplies medical devices, including Medicurtain, an anti-adhesion barrier. The company manages the entire production process from raw materials to finished goods, serving both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-06-27 00:00
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_국내특허취득)
Korean 7.4 KB
2025-06-16 00:00
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_특허취득)
Korean 7.5 KB
2025-05-30 00:00
불성실공시법인지정
Korean 7.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.7 MB
2025-05-15 00:00
[기재정정]분기보고서 (2025.03)
Korean 1.7 MB
2025-05-12 00:00
불성실공시법인지정예고
Korean 6.0 KB
2025-05-08 00:00
횡령ㆍ배임사실확인
Korean 9.5 KB
2025-04-03 00:00
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M002주의 임상 3상 시험 Topline 결과 발표)
Korean 14.8 KB
2025-03-28 00:00
정기주주총회결과
Korean 18.7 KB
2025-03-20 00:00
[첨부추가]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-19 00:00
감사보고서제출
Korean 20.9 KB
2025-03-07 00:00
주주총회소집결의
Korean 7.8 KB
2025-03-07 00:00
주주총회소집공고
Korean 144.2 KB

Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SHINPOONG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.